Department of Medicine, Division of Infectious Diseases and Immunology
Bacterial Infections and Mycoses | Clinical Trials | Female Urogenital Diseases and Pregnancy Complications | Immunology and Infectious Disease | Infectious Disease | Male Urogenital Diseases | Microbiology
The goal of the Sexually Transmitted Infection Clinical Trial Group's Antimicrobial Resistance (AMR) in Neisseria gonorrhoeae (NG) meeting was to assemble experts from academia, government, nonprofit and industry to discuss the current state of research, gaps and challenges in research and technology and priorities and new directions to address the continued emergence of multidrug-resistant NG infections. Topics discussed at the meeting, which will be the focus of this article, include AMR NG global surveillance initiatives, the use of whole genome sequencing and bioinformatics to understand mutations associated with AMR, mechanisms of AMR, and novel antibiotics, vaccines and other methods to treat AMR NG. Key points highlighted during the meeting include: (i) US and International surveillance programs to understand AMR in NG; (ii) the US National Strategy for combating antimicrobial-resistant bacteria; (iii) surveillance needs, challenges, and novel technologies; (iv) plasmid-mediated and chromosomally mediated mechanisms of AMR in NG; (v) novel therapeutic (eg, sialic acid analogs, factor H [FH]/Fc fusion molecule, monoclonal antibodies, topoisomerase inhibitors, fluoroketolides, LpxC inhibitors) and preventative (eg, peptide mimic) strategies to combat infection. The way forward will require renewed political will, new funding initiatives, and collaborations across academic and commercial research and public health programs.
sexually transmitted diseases, Neisseria gonorrhoeae, antimicrobial resistance
Rights and Permissions
Copyright © 2018 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Sexually Transmitted Diseases Association. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
DOI of Published Version
Sex Transm Dis. 2019 Mar;46(3):e18-e25. doi: 10.1097/OLQ.0000000000000929. Link to article on publisher's site
Sexually transmitted diseases
Cristillo AD, Rice PA. (2019). Antimicrobial Resistance in Neisseria gonorrhoeae: Proceedings of the STAR Sexually Transmitted Infection-Clinical Trial Group Programmatic Meeting. Open Access Publications by UMass Chan Authors. https://doi.org/10.1097/OLQ.0000000000000929. Retrieved from https://escholarship.umassmed.edu/oapubs/3815
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.
Bacterial Infections and Mycoses Commons, Clinical Trials Commons, Female Urogenital Diseases and Pregnancy Complications Commons, Immunology and Infectious Disease Commons, Infectious Disease Commons, Male Urogenital Diseases Commons, Microbiology Commons